Signia Therapeutics is pleased to announce that it has been selected to present and participate at the 21st edition of the Venture 5i which will be held on May 30 and 31 at the Grenoble World Trade Center. The presentation will be on May 30 at 18:15 in front of the investors and the company will participate to the One2One meetings with the investors on May 31 in the morning. The Venture 5i is a business meeting on invitation only. The goal of the conference is to identify top 20+ high-growth regional companies and introduce them to key European investors and professionals who can assist in their global expansion.
